| Role of the pyruvate dehydrogenase complex in metabolic remodeling: differential pyruvate dehydrogenase complex functions in metabolism S Park, JH Jeon, BK Min, CM Ha, T Thoudam, BY Park, IK Lee Diabetes & metabolism journal 42 (4), 270-281, 2018 | 182 | 2018 |
| The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases S Park, KW Mathis, IK Lee Reviews in Endocrine and Metabolic Disorders 15, 45-53, 2014 | 141 | 2014 |
| Physiological effect and therapeutic application of alpha lipoic acid S Park, U Karunakaran, N Ho Jeoung, JH Jeon, IK Lee Current medicinal chemistry 21 (32), 3636-3645, 2014 | 136 | 2014 |
| Major role for ACE-independent intrarenal ANG II formation in type II diabetes S Park, BJ Bivona, H Kobori, DM Seth, MC Chappell, E Lazartigues, ... American Journal of Physiology-Renal Physiology 298 (1), F37-F48, 2010 | 114 | 2010 |
| Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury CJ Oh, CM Ha, YK Choi, S Park, MS Choe, NH Jeoung, YH Huh, HJ Kim, ... Kidney international 91 (4), 880-895, 2017 | 97 | 2017 |
| Recent advances in the pathogenesis of microvascular complications in diabetes S Park, HJ Kang, JH Jeon, MJ Kim, IK Lee Archives of Pharmacal Research 42, 252-262, 2019 | 84 | 2019 |
| Low-dose persistent organic pollutants impair insulin secretory function of pancreatic β-cells: human and in vitro evidence YM Lee, CM Ha, SA Kim, T Thoudam, YR Yoon, DJ Kim, HC Kim, ... Diabetes 66 (10), 2669-2680, 2017 | 80 | 2017 |
| Pyruvate dehydrogenase kinase 4 promotes vascular calcification via SMAD1/5/8 phosphorylation SJ Lee, JY Jeong, CJ Oh, S Park, JY Kim, HJ Kim, N Doo Kim, YK Choi, ... Scientific reports 5 (1), 16577, 2015 | 77 | 2015 |
| Activation of Nrf2 by dimethyl fumarate improves vascular calcification CM Ha, S Park, YK Choi, JY Jeong, CJ Oh, KH Bae, SJ Lee, JH Kim, ... Vascular pharmacology 63 (1), 29-36, 2014 | 77 | 2014 |
| Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype BK Min, S Park, HJ Kang, DW Kim, HJ Ham, CM Ha, BJ Choi, JY Lee, ... Frontiers in immunology 10, 944, 2019 | 74 | 2019 |
| Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation SH Choi, S Park, CJ Oh, J Leem, KG Park, IK Lee Vascular Pharmacology 73, 11-19, 2015 | 65 | 2015 |
| Suppression of resting metabolism by the angiotensin AT2 receptor NK Littlejohn, HL Keen, BJ Weidemann, KE Claflin, KV Tobin, KR Markan, ... Cell reports 16 (6), 1548-1560, 2016 | 53 | 2016 |
| Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms CJ Oh, S Park, JY Kim, HJ Kim, NH Jeoung, YK Choi, Y Go, KG Park, ... Redox biology 2, 855-864, 2014 | 52 | 2014 |
| Glomerular filtration rate determinations in conscious type II diabetic mice BJ Bivona, S Park, LM Harrison-Bernard American Journal of Physiology-Renal Physiology 300 (3), F618-F625, 2011 | 44 | 2011 |
| Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells S Park, JK Kim, CJ Oh, SH Choi, JH Jeon, IK Lee Experimental & Molecular Medicine 47 (3), e145-e145, 2015 | 34 | 2015 |
| Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature S Park, BJ Bivona, SM Ford Jr, S Xu, H Kobori, L de Garavilla, ... Hypertension 61 (2), 465-471, 2013 | 33 | 2013 |
| Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice S Park, BJ Bivona, Y Feng, E Lazartigues, LM Harrison-Bernard American Journal of Physiology-Renal Physiology 295 (5), F1504-F1511, 2008 | 32 | 2008 |
| Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases D Lee, HS Pagire, SH Pagire, EJ Bae, M Dighe, M Kim, KM Lee, YK Jang, ... Journal of Medicinal Chemistry 62 (2), 575-588, 2019 | 27 | 2019 |
| Compromised renal microvascular reactivity of angiotensin type 1 double null mice S Park, BJ Bivona, LM Harrison-Bernard American Journal of Physiology-Renal Physiology 293 (1), F60-F67, 2007 | 23 | 2007 |
| Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation BK Min, CJ Oh, S Park, JM Lee, Y Go, BY Park, HJ Kang, DW Kim, JE Kim, ... Experimental & molecular medicine 51 (10), 1-12, 2019 | 20 | 2019 |
